论文部分内容阅读
人ＩＦＮα在治疗淋巴细胞瘤、黑色素瘤、白血病和肾癌等肿瘤疾病，以及预防感冒、治疗乙型肝炎、单纯疱疹等病毒性疾病中，具有广泛的应用前景。据统计，我国约有肿瘤患者３００～４００万人，慢性乙肝患者近１００万人，单纯疱疹及带状疱疹患者约有１亿人以上，估计每年对
Human IFN α has broad application prospects in the treatment of tumor diseases such as lymphoma, melanoma, leukemia and renal cell carcinoma, as well as viral diseases such as preventing colds, treating hepatitis B and herpes simplex. According to statistics, there are about 3 to 4 million cancer patients and nearly 1 million chronic hepatitis B patients in our country. There are about 100 million patients with herpes simplex and shingles.